JEREMY P HOLDSWORTH

Allopathic & Osteopathic Physicians|Family Medicine WILMINGTON, NC NPI 1538245378

General Payments — all program years on this page

$3,916.62

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 239
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $399.04 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $399.0422

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $776.3555
2019 $128.399
2020 $529.4134
2021 $925.8757
2022 $569.5333
2023 $588.0329
2024 $399.0422

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096595460 Novo Nordisk Inc $13.87 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096884186 Novo Nordisk Inc $15.08 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096910029 Novo Nordisk Inc $13.59 11/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096916062 Novo Nordisk Inc $18.74 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097252238 Novo Nordisk Inc $22.16 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097316054 Novo Nordisk Inc $21.73 05/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097489975 Novo Nordisk Inc $18.58 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097523076 Novo Nordisk Inc $14.05 06/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105529488 AstraZeneca Pharmaceuticals LP $21.33 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105738597 AstraZeneca Pharmaceuticals LP $20.84 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115824131 GlaxoSmithKline, LLC. $17.33 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116477825 GlaxoSmithKline, LLC. $18.72 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116594740 GlaxoSmithKline, LLC. $15.64 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117279552 Amgen Inc. $20.35 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117279554 Amgen Inc. $13.81 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118909485 Otsuka America Pharmaceutical, Inc. $24.87 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118909487 Otsuka America Pharmaceutical, Inc. $13.81 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131492625 PFIZER INC. $18.84 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131637093 PFIZER INC. $17.25 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139279560 Astellas Pharma US Inc $14.69 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144598658 Xeris Pharmaceuticals, Inc. $22.53 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147358157 Mylan Specialty L.P. $21.23 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.